Know Cancer

or
forgot password

Molecular Imaging of Breast Cancer With Breast PET/CT


Phase 1
18 Years
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

Molecular Imaging of Breast Cancer With Breast PET/CT


PET is literally a molecular imaging modality. In monitoring the patient's response to a
specific chemotherapeutic regime, baseline and subsequent PET/CT scans can be used to
quantitatively determine the therapeutic effect of the regime, using the standard uptake
value (SUV), a common metric in PET imaging. The breast PET/CT system will facilitate
molecular imaging of breast cancer using a number of radiolabeled molecules, available both
commercially (18-FDG) and from the research environment.


Inclusion Criteria:



- Normal Adult Volunteers

- Female, at least 18 years of age

- Ability to lie motionless for up to 20 minutes

Patient Volunteers

- Female, at least 18 years of age

- Diagnostic findings from prior mammography highly suggestive of invasive breast
carcinoma (BI-RADS category 5)

- Not pregnant or breast-feeding

- Ability to lie motionless for up to 20 minutes

Exclusion Criteria:

- Normal Adult Volunteers

- Inability to understand the risks and benefits of the study

Patient Volunteers

- Recent breast biopsy

- Diagnostic findings from prior mammography highly suggestive of noninvasive ductal or
lobular carcinoma

- Uncontrolled diabetes

- Diabetic and blood sugar level > 200 mg/dL

- Positive urine pregnancy test or currently breast-feeding

- Inability to understand the risks and benefits of the study

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

End-points of this study are whether women will accept the imaging position and timing, and whether functional properties of breast cancer can be imaged with this device.

Outcome Time Frame:

5 years

Safety Issue:

Yes

Principal Investigator

Ramsey Badawi, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of California, Davis

Authority:

United States: Institutional Review Board

Study ID:

200715040

NCT ID:

NCT00584753

Start Date:

April 2007

Completion Date:

July 2011

Related Keywords:

  • Breast Cancer
  • Breast cancer
  • Breast Neoplasms

Name

Location

UC David Medical CenterSacramento, California  95817